The earliest morphological traces of life on Earth are often highly controversial, both because non-biological processes can produce relatively similar structures and because such fossils have often been subjected to advanced alteration and metamorphism. Stromatolites, layered organo-sedimen
A urine or blood test can typically tell doctors if a patient has kidney damage. However, these tests can still miss the very early stages of nephron loss which signal the start of CKD.
Researchers investigating the mechanics of the early stages of lung cancer have identified a new potential treatment, which could also aid early detection of the disease.
New research shows that spine disease, once considered a rarity in chronic recurrent multifocal osteomyelitis, affects as many as 10-35 per cent of patients and is asymptomatic in one-third.
According to research, major societal and political events can have a significant impact on psychological health, as well as sleep and emotional well-being. While conventional wisdom holds that highly anticipated events, such as elections, can cause stress and disrupt well-being.
According to a new RAND Corporation study, the occurrence of dementia in the United States is decreasing among people over the age of 65, dropping 3.7 percentage points from 2000 to 2016.
According to a study, commercial infant meals and formula milk are marketed online, and these marketing strategies are associated with poor parental feeding habits.
As per IIT Jodhpur, the result of the research states that the government and households put together spent substantially more per hospitalisation in private hospitals than in public hospitals.
People with inflammatory bowel diseases develop inflammation of the intestine that can cause thickening of the gut wall and life-threatening blockage of the intestinal tube. Twenty to 50 per cent of people with Crohn's disease and ulcerative colitis are affected over their lifetime by this p
A new drug called Baxdrostat has been shown to significantly reduce high blood pressure (hypertension) in patients who may not respond to current treatments for the condition, according to results from a phase II trial led jointly by a Queen Mary University of London researcher and colleague